Khuong Chau Quang (CIK 0001609405)

Latest company ownership

Shares held
65,398
Last filed at
Jul 8, 2015
Confidence Score
50.0
2025Q4
Confidence Score History
2015Q3 2025Q4
Shares held
21,400
Last filed at
Jun 19, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q1 2025Q4
Role: Director
Shares held
18,000
Last filed at
Jun 15, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q4 2025Q4
Role: Director
Shares held
14,250
Last filed at
Jun 23, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q2 2025Q4
Shares held
1,875
Last filed at
Oct 13, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 2, 2020 Nov 4, 2020 Galecto, Inc. Director Buy 100.0 +733,333 25.48% $11M
Aug 17, 2020 Aug 19, 2020 Inspire Medical Systems, Inc. Director Sell 15.0 -138,443 -98.73% $14.9M
Aug 12, 2020 Aug 14, 2020 Inspire Medical Systems, Inc. Director Sell 15.0 -92,167 -15.93% $10M
Aug 7, 2020 Aug 11, 2020 Inspire Medical Systems, Inc. Director Sell 15.0 -116,570 -33.42% $12.3M
Mar 6, 2020 Mar 10, 2020 Inspire Medical Systems, Inc. Director Sell 15.0 -500,000 -58.93% $41.8M
Mar 3, 2020 Mar 5, 2020 Inspire Medical Systems, Inc. Director Sell 15.0 -500,000 -37.08% $42.1M
Nov 26, 2019 Nov 29, 2019 Inspire Medical Systems, Inc. Director Sell 22.5 -124,000 -8.42% $8.8M
May 13, 2019 May 13, 2019 NextCure, Inc. Director Buy 100.0 +350,000 14.82% $5.3M
Mar 7, 2019 Mar 11, 2019 Inspire Medical Systems, Inc. Director Sell 15.0 -358,449 -19.59% $20.5M
Dec 11, 2018 Dec 13, 2018 Inspire Medical Systems, Inc. Director Sell 15.0 -614,772 -25.15% $23.1M
Jun 28, 2018 Jul 2, 2018 Whitehawk Therapeutics, Inc. Director Buy 100.0 +777,500 17.60% $3M
May 7, 2018 May 9, 2018 Inspire Medical Systems, Inc. Director Buy 100.0 +312,500 14.66% $5M
Mar 15, 2017 Mar 17, 2017 Whitehawk Therapeutics, Inc. Director Buy 100.0 +762,995 20.88% $3.8M
Jul 6, 2015 Jul 8, 2015 PALVELLA THERAPEUTICS, INC. Director Buy 95.0 +500,000 7.40% $1.4M